Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

266 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting.
Manosuthi W, Chaovavanich A, Tansuphaswadikul S, Prasithsirikul W, Inthong Y, Chottanapund S, Sittibusaya C, Moolasart V, Termvises P, Sungkanuparph S. Manosuthi W, et al. Among authors: sungkanuparph s. J Infect. 2007 Nov;55(5):464-9. doi: 10.1016/j.jinf.2007.07.002. Epub 2007 Aug 22. J Infect. 2007. PMID: 17714788
Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study.
Vibhagool A, Sungkanuparph S, Mootsikapun P, Chetchotisakd P, Tansuphaswaswadikul S, Bowonwatanuwong C, Ingsathit A. Vibhagool A, et al. Among authors: sungkanuparph s. Clin Infect Dis. 2003 May 15;36(10):1329-31. doi: 10.1086/374849. Epub 2003 May 2. Clin Infect Dis. 2003. PMID: 12746781 Clinical Trial.
Chronic neck ulcer in an immunocompetent host.
Manosuthi W, Malathum K, Sungkanuparph S, Laothamatah J, Vorachit M, Nitiyanant P. Manosuthi W, et al. Among authors: sungkanuparph s. Lancet Infect Dis. 2005 Mar;5(3):190. doi: 10.1016/S1473-3099(05)01313-7. Lancet Infect Dis. 2005. PMID: 15766655 No abstract available.
Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin.
Manosuthi W, Sungkanuparph S, Thakkinstian A, Vibhagool A, Kiertiburanakul S, Rattanasiri S, Prasithsirikul W, Sankote J, Mahanontharit A, Ruxrungtham K. Manosuthi W, et al. Among authors: sungkanuparph s. AIDS. 2005 Sep 23;19(14):1481-6. doi: 10.1097/01.aids.0000183630.27665.30. AIDS. 2005. PMID: 16135901 Clinical Trial.
Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosis.
Sungkanuparph S, Overton ET, Seyfried W, Groger RK, Fraser VJ, Powderly WG. Sungkanuparph S, et al. Clin Infect Dis. 2005 Nov 1;41(9):1326-32. doi: 10.1086/496985. Epub 2005 Sep 29. Clin Infect Dis. 2005. PMID: 16206110
266 results